These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7193103)

  • 1. Spontaneous rosetting characteristics of prostaglandin (PG)-treated lymphocytes from patients with solid neoplasias.
    Misefari A; Venza-Teti D; Teti G; La Via MF; Rust PF
    Clin Immunol Immunopathol; 1981 Jan; 18(1):85-94. PubMed ID: 7193103
    [No Abstract]   [Full Text] [Related]  

  • 2. Spontaneous rosette-forming lymphocyte sensitivity to prostaglandins in patients with cervical carcinoma after surgery.
    Venza Teti D; Misefari A; Sofo V; La Via MF
    Diagn Immunol; 1985; 3(2):62-6. PubMed ID: 3862497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E-rosette formation in normals and patients with multiple sclerosis: effect of prostaglandin and aspirin.
    Dore-Duffy P; Zurier RB
    Clin Immunol Immunopathol; 1979 Jul; 13(3):261-8. PubMed ID: 455803
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunoprofile studies for patients with bronchogenic carcinoma--III. Multivariate analysis of immune tests in correlation with survival.
    Concannon JP; Dalbow MH; Davis W; Hodgson SE; Mitchell J; Markopoulos E
    Int J Radiat Oncol Biol Phys; 1978; 4(3-4):255-61. PubMed ID: 646868
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of prostaglandins on complement receptors of human lymphocytes.
    Venza-Teti D; Misefari A
    Adv Prostaglandin Thromboxane Res; 1980; 8():1747-9. PubMed ID: 7377021
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro modulation of cell-mediated immunity by prostaglandin E2. II. Enhancement of spontaneous plaque-forming cell generation.
    Antonaci S; Jirillo E; Montemurro P; Barbaro L; Bonomo L; Fumarola D
    Prostaglandins Leukot Med; 1982 Sep; 9(3):295-300. PubMed ID: 6752957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Electrophoretic mobility of lymphocytes in multiple myeloma and bronchial cancer].
    Ricci C; Cascio G; Alemanno L; Anania A; Gallarate G; Omedè P; Valente E
    Minerva Med; 1979 Sep; 70(42):2855-61. PubMed ID: 386169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immune status of patients with bronchial cancer].
    Aulenbacher P; Manke HG; Drings P
    Klin Wochenschr; 1987 May; 65(10):445-52. PubMed ID: 3037180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional response of lymphatic tissue in bronchogenic cancer.
    Fiser F; Macholda F; Pátek J; Sobĕslavský O; Procházka J; Stulíková V
    Czech Med; 1983; 6(4):218-24. PubMed ID: 6420126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunological examination of patients with bronchogenic carcinoma (author's transl)].
    Foltýnová V; Mostecký H; Dienstbier Z; Hlavatý V; Koprivová H; Rezný Z
    Sb Lek; 1980 Mar; 82(3):89-96. PubMed ID: 7367805
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunologic assays in lung cancer. Skin tests, lymphocyte blastogenesis, and rosette-forming cell count.
    Brugarolas A; Han T; Takita H; Minowada J
    N Y State J Med; 1973 Mar; 73(6):747-50. PubMed ID: 4510958
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative evaluation of lymphocyte subpopulations, delayed cutaneous hypersensitivity reactions and autoantibody formation in cancer patients.
    Pichler WJ; Stingl G; Wagner G; Micksche M; Neumann H; Knapp W
    Osterr Z Onkol; 1977 Nov; 4(5-6):110-7. PubMed ID: 202907
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of prostaglandins on mouse erythrocyte rosette-forming human lymphocytes.
    Misefari A; Venza-Teti D; LaVia MF
    Immunopharmacology; 1980 Apr; 2(2):109-15. PubMed ID: 6969242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of immune reactions against cultured hamartoma cells with lymphocytes from patients with bronchogenic carcinoma.
    Pierce GE; Allingham R; Bell JW
    Surg Forum; 1972; 23(0):89-91. PubMed ID: 4671035
    [No Abstract]   [Full Text] [Related]  

  • 15. Decrease of prostaglandin-sensitive mouse erythrocyte rosette-forming lymphocytes in human neoplasias.
    Misefari A; Venza-Teti D; La Via MF
    Cell Immunol; 1979 Oct; 47(2):437-8. PubMed ID: 487452
    [No Abstract]   [Full Text] [Related]  

  • 16. The fluctuation of circulating immune complexes level in patients with malignancy.
    Vodvárka P; Vodvárka T; Foukalová J
    Neoplasma; 1984; 31(4):485-9. PubMed ID: 6472521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressor cell activity of lymphocytes infiltrating human lung and breast tumours.
    Vose BM; Moore M
    Int J Cancer; 1979 Nov; 24(5):579-85. PubMed ID: 160895
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytotoxic activity of lymphocytes to bronchogenic carcinoma cells in patients with lung cancer.
    Yasumoto K; Ohta M; Nomoto K
    Gan; 1976 Aug; 67(4):505-11. PubMed ID: 1030675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface markers of blood lymphocytes in bronchial carcinoma.
    Bodolay E; Szabó G; Juhász I; Komoróczy Z; Diczházy A
    Acta Med Hung; 1984; 41(2-3):121-7. PubMed ID: 6611544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased circulating T alpha lymphocyte population in bronchogenic and colonic carcinoma.
    Pucci A; Clancy RL; Doe WF
    Clin Exp Immunol; 1981 Oct; 46(1):130-3. PubMed ID: 6978211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.